Funding for this research was provided by:
Wellcome Trust (072064)
Received: 21 February 2020
Accepted: 6 December 2020
First Online: 14 December 2020
Ethics approval and consent to participate
: The Senate Research and Publications Committee of the Muhimbili University of Health and Allied Sciences (MUHAS) in Tanzania approved the study (Ref. No.DA.282/298/01.C/). Permission to publish the secondary data was obtained from Principle Investigator of MUHAS Sickle Cell Program.
: Not applicable.
: The authors declare that they have no competing interests.